Mattias Landfors

Years Active: 2023-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Lien Provez, Tom Putteman, Mattias Landfors, Juliette Roels, Lindy Reunes, Sara T'Sas, Wouter Van Loocke, Béatrice Lintermans, Stien De Coninck, Morgan Thenoz, Wouter Sleeckx, Natalia Maćkowska, Tom Taghon, Marc R Mansour, Nadine Farah, Koen Norga, Peter Vandenberghe, Rishi Sury Kotecha, Steven Goossens, Sofie Degerman, Renate De Smedt, Pieter Van Vlierberghe
Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma. Cancers 15 (3) (2023)
Lien Provez, Tom Putteman, Mattias Landfors, Juliette Roels, Lindy Reunes, Sara T'Sas, Wouter Van Loocke, Béatrice Lintermans, Stien De Coninck, Morgan Thenoz, Wouter Sleeckx, Natalia Maćkowska, Tom Taghon, Marc R Mansour, Nadine Farah, Koen Norga, Peter Vandenberghe, Rishi Sury Kotecha, Steven Goossens, Sofie Degerman, Renate De Smedt, Pieter Van Vlierberghe
Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma. Cancers 15 (3) (2023)

Mattias Landfors.css-eqlu8i{font-size:small;padding-left:4px;}